SIBIONICS et PharmaSens explorent de nouvelles perspectives pour l'administration automatisée d'insuline lors du congrès de l'EASD 2026

ConferencePositive

AI Analysis

Summary

SiBionics presented a platform linking continuous glucose monitoring with automated insulin administration at the EASD 2026 congress in collaboration with PharmaSens, focusing on earlier intervention in diabetes management.

Importance:4/10

Sentiment:

0.30

diabetesinsulin deliveryautomated administrationcontinuous monitoringEASD 2026partnership

Read the original article

Published by PR Newswire Biotech on October 5, 2026 12:47 AM

Read Original